137 related articles for article (PubMed ID: 11563455)
1. Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
Taylor AA
BJOG; 2001 Sep; 108(9):1011-2. PubMed ID: 11563455
[No Abstract] [Full Text] [Related]
2. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.
Ludwig RJ; Beier C; Lindhoff-Last E; Kaufmann R; Boehncke WH
Contact Dermatitis; 2003 Sep; 49(3):158-9. PubMed ID: 14678213
[No Abstract] [Full Text] [Related]
3. [Use of low molecular weight heparins by dermatologists].
Maakaroun A; Gruel Y
Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
[No Abstract] [Full Text] [Related]
4. [Delayed intracutaneous test reaction in heparin intolerance].
Wurpts G; Merk HF
Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
[No Abstract] [Full Text] [Related]
5. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
Liew G; Campbell C; Thursby P
ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
[No Abstract] [Full Text] [Related]
6. Delayed-type skin reaction to the heparin-alternative danaparoid.
Szolar-Platzer C; Aberer W; Kränke B
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
[TBL] [Abstract][Full Text] [Related]
7. [Current treatment concepts in heparin-induced thrombocytopenia].
Ranze O; Greinacher A
Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
[No Abstract] [Full Text] [Related]
8. Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
Macchi L; Sarfati R; Guicheteau M; Chamlian V; Pourrat O; Gruel Y; Magnin G; Brizard A; Boinot C
Clin Appl Thromb Hemost; 2000 Oct; 6(4):187-9. PubMed ID: 11030522
[TBL] [Abstract][Full Text] [Related]
9. [Delayed hypersensitivity to heparins and heparinoids].
Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
[TBL] [Abstract][Full Text] [Related]
10. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
[No Abstract] [Full Text] [Related]
11. Thromboprophylaxis in hip fracture surgery: a pilot study comparing danaparoid, enoxaparin and dalteparin. The TIFDED Study Group.
Haemostasis; 1999; 29(6):310-7. PubMed ID: 10844404
[TBL] [Abstract][Full Text] [Related]
12. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Herzog S; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
[TBL] [Abstract][Full Text] [Related]
13. A comparative review of the adverse effect profiles of heparins and heparinoids.
Borris LC; Lassen MR
Drug Saf; 1995 Jan; 12(1):26-31. PubMed ID: 7537967
[TBL] [Abstract][Full Text] [Related]
14. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
Fernandes P; Mayer R; MacDonald JL; Cleland AG; Hay-McKay C
Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
[TBL] [Abstract][Full Text] [Related]
15. Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment.
Dworschak M; Hiesmayr JM; Lassnigg A
Ann Thorac Surg; 2002 May; 73(5):1626-7. PubMed ID: 12022563
[TBL] [Abstract][Full Text] [Related]
16. Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.
Seitz CS; Brocker EB; Trautmann A
Dermatol Online J; 2008 Sep; 14(9):4. PubMed ID: 19061586
[TBL] [Abstract][Full Text] [Related]
17. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
[No Abstract] [Full Text] [Related]
18. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
Murphy GS; Marymont JH
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
[No Abstract] [Full Text] [Related]
19. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
Kodityal S; Manhas AH; Udden M; Rice L
Eur J Haematol; 2003 Aug; 71(2):109-13. PubMed ID: 12890149
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
Counsell C; Sandercock P
Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
